Who invests in PDAC
309 investors in 114 private rounds of 55 companies with PDAC programs, active or discontinued.
One lane per company with at least one private round. Bubble area = round size in USD; color = round stage. The bars on top add up each year's disclosed rounds with a known year. Click a company or a bubble for details.
Round stage:Founding & seedSeries ASeries BSeries C & later privateRound not disclosed
Marks:bubble area = round size (USD)size not disclosedyear estimatedAaDiscontinued (muted)
← Scroll to see all years →
Investors (left, by the stage of their earliest round in PDAC) and the companies they funded (right). One ribbon per investor and company. Click a name, a stage or a ribbon for details; Shift-, Cmd- or Ctrl-click to compare.
Investor type:
Ribbon color = investor group:Independent VC & venture creationPharma & corporate VCCrossover & family officeUniversity, non-profit & publicType not stated
← Scroll to see all companies →
Current owners of active programs (not counting academic repurposing trials) with no private round on this map.
Big pharma and academic (own budget) (40)
- AbbVie
- Amgen
- Astellas
- AstraZeneca
- BMS
- CAMS Cancer Hospital
- Changhai Hospital
- City of Hope
- Daiichi Sankyo
- First Affiliated Hospital of Wenzhou Medical University
- GSK
- Hainan Cancer Hospital
- Hangzhou First People's Hospital
- Hengrui
- Incyte
- Johns Hopkins
- Lilly
- MD Anderson
- Merck & Co.
- Merck KGaA
- Nanjing Drum Tower Hospital
- NCI
- Northwestern
- Novartis
- Peking University
- Penn
- Pfizer
- Roche (Genentech)
- Ruijin Hospital
- Sanofi (Blueprint)
- Second Affiliated Hospital of Guangzhou Medical University
- Servier
- Sino Biopharm (CTTQ)
- SUGH
- SYSU
- Tianjin Cancer Hospital
- UNC Lineberger
- University Hospital Tuebingen
- WashU Medicine
- Zhongshan Hospital
Other companies (no public data about private funding) (115)
- 3SBio
- Abbisko
- AbilityPharma
- ADT Pharma
- Agenus
- AIM ImmunoTech (FKA Hemispherx Biopharma)
- Akeso
- Allist
- Amphera
- Amplia
- Anocca
- Arcus
- Armida
- ArriVent
- Arvinas
- Auricula
- Avacta
- Baili-Bio
- Beijing Biotech
- Betta
- Bicycle
- BioNTech
- Bold
- Cambium
- Can-Fite
- CanBas
- Cantargia
- Cardiff Oncology
- CG Pharma
- Chipscreen
- Circio
- Corcept
- Dong-A ST
- Duke Street Bio
- Duo Oncology
- Eleison
- Elicio
- EnGeneIC
- Erasca
- Essen Biotech
- Exelixis
- Fred Hutchinson Cancer Center
- FutureGen
- GC Cell
- GI Innovation
- Haisco
- Hansoh
- Henlius
- HUTCHMED
- I-Mab
- IDEAYA
- Immuneering
- ImmuneOncia
- ImmunityBio
- ImmunoGenesis
- Innovent
- Ionova
- Jacobio
- Janux
- Kelun-Biotech
- Kestrel
- Keymed
- Kura
- Kvvit
- Lantern
- Legend
- Lepu
- Leukogene
- LigaChem
- Lisata
- Loki
- Lumara
- MacroGenics
- Majory
- Marker
- Medigen
- Migra
- Monopar
- MuCommune
- Nammi
- Nelum
- New Cancer Cure-Bio
- Nuvation
- Oncolytics
- Onconic
- OncoTab
- Oncotelic
- OSE
- Panbela
- ParVation
- Philogen
- Prestige
- ProDa
- Qilu
- RasCal
- RevMed
- Rgene
- Salspera
- Sanguine
- Senhwa
- Silexion
- SK Life Science
- Sutro
- Syntrix
- Tango
- Tezcat
- Theriva
- Thetis
- TME Pharma
- Traverse
- Tyligand
- Uinta
- Verastem
- Xinhe
- XtremisBio